Just a month after Tarrytown , New York-based Regeneron received approval from the Food and Drug Administration for its cholesterol-fighting drug Praluent, the FDA has approved a similar drug by California-based Amgen Inc., the Wall Street Journal reports.
http://ift.tt/1PCEUQc
No comments:
Post a Comment